ESMO Targeted Anticancer Therapies Congress 2025

The ESMO Targeted Anticancer Therapies (TAT) Congress is a premier event focused on early drug development in oncology. It aims to enhance the conduct of early-phase clinical trials by showcasing the latest scientific advancements, preclinical and early clinical data, and hosting educational workshops.

The Congress serves as a multidisciplinary forum, bringing together experts from academia, industry, regulatory bodies, and investor communities to foster collaboration, highlight innovative approaches, and address challenges in the development of novel anticancer therapies.

---